Roflumilast (Daliresp)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Roflumilast (Daliresp), covering 2016-10-26 to 2016-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study [Phase 2]